Scholar : These new articles for Xenobiotica are available online

@media screen and (max-width:400px) { .two .column, .two .left, .two .right{ max-width: 100% !important; } } @media screen and (min-width: 401px) and (max-width:620px){ .two .column, .two .left, .two .right { max-width: 100% !important; } }

The online platform for Taylor & Francis Online content New for Xenobiotica and online now on Taylor & Francis Online: Original Articles The metabolism and drug-drug interaction potential of the selective prostacyclin receptor agonist selexipag Carmela Gnerre, Jérôme Segrestaa, Swen Seeland, Päivi Äänismaa, Thomas Pfeifer, Stephane Delahaye, Ruben de Kanter, Tomohiko Ichikawa, Tetsuhiro Yamada & Alexander Treiber Pages: 1-50 | DOI: 10.1080/00498254.2017.1357088This is the author accepted version which has not been proofed or edited Quantitative in vitro phenotyping and prediction of drug interaction potential of CYP2B6 substrates as victims Raghava Choudary Palacharla, Ramakrishna Nirogi, Venkatesham Uthukam, Arunkumar Manoharan, Ranjith Kumar Ponnamaneni & Ilayaraja Kalaikadhiban Pages: 1-43 | DOI: 10.1080/00498254.2017.1354267This is the author accepted version which has not been proofed or edited Research Article In vitro evaluation of the inhibition and induction potential of olaparib, a potent poly(ADP-ribose) polymerase inhibitor, on cytochrome P450 Alex McCormick, Helen Swaisland, Venkatesh Pilla Reddy, Maria Learoyd & Graeme Scarfe Pages: 1-10 | DOI: 10.1080/00498254.2017.1346332 Absorption, metabolism and excretion of [14C]omarigliptin, a once-weekly DPP-4 inhibitor, in humans Shiyao Xu, Dan Tatosian, Ian Mcintosh, Maria Caceres, Catherine Matthews, Koppara Samuel, Diana Selverian, Sanjeev Kumar & Eunkyung Kauh Pages: 1-8 | DOI: 10.1080/00498254.2017.1346333 Identification of three new phase II metabolites of a designer drug methylone formed in rats by N-demethylation followed by conjugation with dicarboxylic acids Monika Židková, Igor Linhart, Marie Balíková, Michal Himl, Veronika Dvořáčková, Eva Lhotková & Tomáš Páleníček Pages: 1-8 | DOI: 10.1080/00498254.2017.1349964 Altered hepatic drug-metabolizing activity in rats suffering from hypoxemia with experimentally induced acute lung impairment Yuki Hori, Yasumasa Shimizu & Tetsuya Aiba Pages: 1-8 | DOI: 10.1080/00498254.2017.1349969 Effects of aging and rifampicin pretreatment on the pharmacokinetics of human cytochrome P450 probes caffeine, warfarin, omeprazole, metoprolol and midazolam in common marmosets genotyped for cytochrome P450 2C19 Akiko Toda, Shotaro Uehara, Takashi Inoue, Masahiro Utoh, Takashi Kusama, Makiko Shimizu, Yasuhiro Uno, Masayuki Mogi, Erika Sasaki & Hiroshi Yamazaki Pages: 1-7 | DOI: 10.1080/00498254.2017.1353716 Marmoset pulmonary cytochrome P450 2F1 oxidizes biphenyl and 7-ethoxycoumarin and hepatic human P450 substrates Shotaro Uehara, Yasuhiro Uno, Toru Oshio, Takashi Inoue, Erika Sasaki & Hiroshi Yamazaki Pages: 1-7 | DOI: 10.1080/00498254.2017.1354138 Induction of human cytochrome P450 3A4 by the irreversible myeloperoxidase inactivator PF-06282999 is mediated by the pregnane X receptor Jamie E. Moscovitz, Zhiwu Lin, Nathaniel Johnson, Meihua Tu, Theunis C. Goosen, Yan Weng & Amit S. Kalgutkar Pages: 1-9 | DOI: 10.1080/00498254.2017.1353163 To update which email alerts you receive, manage your alerts within the My Account area. You can also unsubscribe from this alert with one click. If you need any further help, please contact us at support@tandfonline.com Please do not reply to this email. To ensure that you receive your alerts and information from Taylor & Francis Online, please add "alerts@tandfonline.com" and "info@tandfonline.com" to your safe senders list. Taylor & Francis, an Informa business. Taylor & Francis is a trading name of Informa UK Limited, registered in England under no. 1072954. Registered office: 5 Howick Place, London, SW1P 1WG.